Skip to Main Content
Advertisement intended for health care professionals
Close
ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Blood
Blood Advances
Blood Neoplasia
Blood Vessels, Thrombosis & Hemostasis
Hematology
The Hematologist
International
Blood Chinese Edition
Blood Italian Edition
Blood Latin America Edition
Blood Spanish Edition
ASH
ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store
Cart
User Tools Dropdown
Cart
Sign In
Search Dropdown Menu
header search
search input
Search input auto suggest
filter your search
All Content
All Journals
Blood Advances
Search
Toggle Menu
Menu
Issues
Current Issue
All Issues
Latest Articles
First Edition
Latest Articles
Guidelines
Collections
Collections
Special Collections
Multimedia
Alerts
Author Center
Submit
Author Guide
Style Guide
Why Submit to Blood Advances?
About
About Blood Advances
Editorial Board and Staff
Copyright
Alerts
Skip Nav Destination
Issue Archive
Select Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
Issue
January 9 - Volume 8, Issue 1, Pages 1 - 259
January 23 - Volume 8, Issue 2, Pages 261 - 511
February 13 - Volume 8, Issue 3, Pages 513 - 828
February 27 - Volume 8, Issue 4, Pages 829 - 1061
March 12 - Volume 8, Issue 5, Pages 1063 - 1344
March 26 - Volume 8, Issue 6, Pages 1345 - 1585
April 9 - Volume 8, Issue 7, Pages 1587 - 1833
April 23 - Volume 8, Issue 8, Pages 1835 - 2057
May 14 - Volume 8, Issue 9, Pages 2059 - 2325
May 28 - Volume 8, Issue 10, Pages 2327 - 2599
June 11 - Volume 8, Issue 11, Pages 2601 - 2990
June 25 - Volume 8, Issue 12, Pages 2991 - 3343
July 9 - Volume 8, Issue 13, Pages 3345 - 3606
July 23 - Volume 8, Issue 14, Pages 3607 - 3858
August 13 - Volume 8, Issue 15, Pages 3859 - 3945
Volume 8, Issue 15
August 13 2024
In Progress
Close navigation menu
In this Issue
Plasma Cell Disorders
RESEARCH LETTER
MYELOID NEOPLASIA
THROMBOSIS AND HEMOSTASIS
Issue Navigation
Plasma Cell Disorders
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Mateo Mejia Saldarriaga
,
Darren Pan
,
Caitlin Unkenholz
,
Tarek H. Mouhieddine
,
Juan Esteban Velez-Hernandez
,
Katherine Engles
,
Joshua A. Fein
,
Jorge Monge
,
Cara Rosenbaum
,
Roger Pearse
,
David Jayabalan
,
Christian Gordillo
,
Hei Ton Chan
,
Samuel Yamshon
,
Santiago Thibaud
,
Markus Mapara
,
Giorgio Inghirami
,
Suzanne Lentzsch
,
Ran Reshef
,
Adriana Rossi
,
Samir Parekh
,
Sundar Jagannath
,
Shambavi Richard
,
Ruben Niesvizky
,
Mark Bustoros
View Article
titled, Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Supplemental data
RESEARCH LETTER
Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study
Gaukhar Baidildinova
,
Vincent ten Cate
,
Marina Panova-Noeva
,
Bianca Dahlen
,
Alexander Gieswinkel
,
Saskia von Ungern-Sternberg
,
Steffen Rapp
,
Konstantin Strauch
,
Manfred E. Beutel
,
Norbert Pfeiffer
,
Karl J. Lackner
,
Thomas Münzel
,
Hugo ten Cate
,
Philipp S. Wild
,
Kerstin Jurk
View Article
titled, Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study
Supplemental data
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia
Esperanza Martín-Sánchez
,
Laura Blanco
,
Peter S. Kim
,
Kamlesh Bisht
,
Hongfang Wang
,
Helgi Van de Velde
,
Tomas Jelinek
,
Catia Simoes
,
Felipe Prosper
,
Jesus F. San Miguel
,
Ana Alfonso
,
Juan Bergua
,
Rebeca Rodríguez-Veiga
,
Susana Vives
,
David Martínez-Cuadrón
,
Pau Montesinos
,
Bruno Paiva
,
Aintzane Zabaleta
View Article
titled, Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia
Supplemental data
MYELOID NEOPLASIA
Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia
Tejashree Joglekar
,
Alexander Chin
,
Alin Voskanian-Kordi
,
Seungchul Baek
,
Azim Raja
,
Apurv Rege
,
Weiliang Huang
,
Maureen Kane
,
Marikki Laiho
,
Thomas R. Webb
,
Xiaoxuan Fan
,
Michael Rubenstein
,
Charles J. Bieberich
,
Xiang Li
View Article
titled, Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia
Supplemental data
THROMBOSIS AND HEMOSTASIS
Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B
Meng Gao
,
Long Chen
,
Jinlong Yang
,
Shixia Dong
,
Qing Cao
,
Zihan Cui
,
Yanyan Dong
,
Hongli Liu
,
Yan Shen
,
Haiping Yang
,
Zhenyu Hao
,
Lei Zhang
,
Weikai Li
,
Jian-Ke Tie
,
Guomin Shen
View Article
titled, Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B
Supplemental data
Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice
Gagan D. Flora
,
Madankumar Ghatge
,
Manasa K. Nayak
,
Tarun Barbhuyan
,
Mariia Kumskova
,
Anil K. Chauhan
View Article
titled, Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice
Supplemental data
All Issues
Advertisement intended for health care professionals
Email alerts
Continuous Publishing Alert
New Journal Content Alert
Close Modal
Latest
Most Read
Most Cited
Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B
Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice
Advertisement intended for health care professionals
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
Advertisement intended for health care professionals
close advertisement
